CT-scan in a coronal section showing an adenoid cystic carcinoma as an...
CT-scan in a coronal section showing an adenoid cystic carcinoma as an inhomogeneous mass in the right maxillary sinus with infiltration of neighboring structures.

Image source: Dudde et al., Oncoscience 22023 (CC BY 3.0)

News • Adenoid cystic carcinoma

Treatment strategies for head and neck cancer

In a new editorial paper, researchers Florian Dudde, Kai-Olaf Henkel and Filip Barbarewicz from the Army Hospital Hamburg discuss treatment strategies for head and neck tumors.

The paper was published in Oncoscience

In this anatomical region, squamous cell carcinoma (SCC) is the most common malignant entity. However, there are also other malignant tumors that, unlike SCC, originate in the salivary glands of the head and neck region, such as mucoepidermoid carcinoma or adenoid cystic carcinoma (ACC). 

Proton therapy, as a special form of radiotherapy, seems to have decisive advantages with regard to the long-term survival of this highly malignant tumor originating from the small salivary glands

Dudde et al.

In general, tumors originating from the minor salivary glands often show a higher degree of malignancy than tumors of the major salivary glands (parotid gland, submandibular gland, sublingual gland). Consequently, the ACC in particular is often localized in the area of the hard palate (small salivary glands). In rare cases, ACC has also been described in other regions of the head and neck region, such as the paranasal sinuses or the tongue. “In principle, ACC grow slowly and consequently often cause a lack of clinical symptoms,” the researchers point out. 

Their perivascular and perineural growth pattern can present therapeutic challenges, particularly in the head and neck region. The treatment of ACC in the head and neck region consists of surgical tumor resection with subsequent neck dissection and one- or two-stage plastic defect reconstruction. Severe ACC often require adjuvant radiotherapy. “Proton therapy, as a special form of radiotherapy, seems to have decisive advantages with regard to the long-term survival of this highly malignant tumor originating from the small salivary glands.” 


Source: Impact Journals LLC

08.08.2023

Related articles

Photo

News • Tumor microenvironment in nasopharyngeal carcinoma

Towards more personalized treatment of nose cancer

Molecular profiling of over 1,000 nasopharyngeal cancer (NPC) tumours reveals distinct differences in tumour microenvironment of locoregionally advanced NPC, supporting personalised treatment.

Photo

News • Dual targeting radioligand

“Smart missile” radiopharmaceutical shows promise against multiple cancers

New research makes a strong case for a new dual-targeting radiopharmaceutical, designed to attach to two vulnerable sites on cancer cells, enabling more precise and potent therapy.

Photo

News • Surprising insights

Research explains how tumor cells die after radiotherapy

Why does radiation therapy kill cancer cells from the same tumour in different ways? This has long remained poorly understood. Now, new findings open up opportunities to improve treatment.

Related products

Subscribe to Newsletter